The $15 billion ad-powered AI startup your doctor may already be using
Summary
OpenEvidence is a Miami-based startup that created an AI-powered search engine used by nearly two-thirds of U.S. doctors to help diagnose and treat patients. The company uses advertisements to fund its platform, has grown rapidly since 2022, and is valued at $15 billion after raising $250 million in its latest funding round.Key Facts
- OpenEvidence was founded in 2022 by Daniel Nadler.
- Nearly 2 out of 3 U.S. doctors use OpenEvidence’s AI chatbot regularly.
- Last month, doctors made over 42 million requests using the platform.
- The tool searches trusted medical journals and clinical guidelines to support doctors’ decisions.
- The company earned nearly $1 billion in investment from big firms like Andreessen Horowitz and Sequoia.
- OpenEvidence expects to earn $400–500 million through ads by the end of 2026.
- It has partnerships with hospitals like Mount Sinai and Memorial Sloan Kettering.
- The startup withdrew from the EU and UK due to concerns about new AI regulations.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
